Safe diabetes care - Diabeter

Diabeter has been accredited he Qualicor Europe quality mark at Gold level since August 2022 (until August 2027). Previously, we were accredited to the HKZ client/patient safety standard, which, as the standard indicates, mainly focused on safety. This Qualicor accreditation indicates that Diabeter:

  • Guarantees the safety of patients, employees, visitors and the environment 
  • Has a culture which is aimed at continuous improvement of quality and safety as well as at safeguarding the improvements made
  • Has designed the management and organization of the (care) processes in such a way that they reasonably and reproducibly lead to responsible care

Diabeter is very proud of this result, which is mainly due to the great efforts of all our employees.

Audit June 2022

From June 14 to 16 we welcomed a team of 3 auditors. Through conversations with healthcare professionals, employees, patients and family members, they investigated whether we provide high-quality and safe care. Based on what the audit team saw, Diabeter received compliments:

  • the enthusiasm and involvement of employees
  • tailor-made care: person-oriented & joint decision-making with patients and the environment
  • extensive education for employees and patients
  • integral quality system (digital)

What is next?

Over the next 5 years, we will receive a visit from Qualicor every 20 months, the so-called sequential assessment program (consisting of 3 smaller audits). In this way, we at Diabeter continue to continuously improve. For more information, visit the Qualicor Europe website.

Safe diabetes care

The care we give to children and young adults with type I diabetes is meant to give them a good quality of life. This automatically means that the care must be safe. In 2013 we’ve worked out our attention to the safety-issue in a safety management program that is now the basis for all work at Diabeter. The core of this program is taking stock in all risks that might occur at Diabeter and preventing problems and dangers in the care we provide.

To this end we perform audits in which we test our care and our people. Patient safety is an integral part of all we do. To us the experience of our patients is a valuable way to monitor our care and make it better. With this we also ask our patients how they are doing. This is called patient-related outcome measurements (PROMs). It is an important part of our evaluations. Spontaneous suggestions for improvement of our quality and safety are always welcome via our safety coordinator Marja Buijs: or clië

Your rights as a patient

Of course we will try to optimally coordinate your treatment (or that of your child) with you in good consultation. Hereby we draw your attention to your rights as a patient.


According to the law, we as your practitioner must fully inform you about any medical examination or treatment you have to undergo. This is necessary for you to be able to decide whether or not you want the examination or treatment. If you feel that you are missing information, or if things are unclear, ask your practitioner for an explanation.

Treatment consent and provision of information

Consent up to 11-year-olds:

If your doctor proposes treatment or an examination, your (oral) permission is always required. For children up to 11 years old, the parents decide.

Consent 12 to 15 year olds:

For children aged 12 to 15, both the parents and the child must give consent. Adolescents 16 and older may decide on their own treatment. Of course, children under the age of 16 must be involved in making decisions about medical treatments or examinations.

Consent 16 to 17 year olds:

From the age of 16, by law, you must make your own decisions about your care and treatment. According to the law, we then only inform you about your treatment and appointments and no longer your parents. This means that from the age of 16 we are no longer allowed to give information to your parents about your treatment. This concerns all mail from Diabeter, including your treatment team, therapy mail, appointment confirmations and newsletters. It also includes information that we are not allowed to give to your parents by phone.

Giving permission

If you are 16 or 17 and you would still like your parents to be informed about your treatment, you can. However, legally we do need your permission to do so. If you want to give your permission, please fill in the form that you can ask for at our reception desk. You can change your permission at any time at our reception desk.
This consent will only apply until you are 18 years old! After that, only you will be informed automatically.

More information about your rights as a patient can be found on  and on 

Access to medical files

As a patient you are allowed to inspect your medical file or request a copy of it. Children up to 11 years old do not have the right to inspect their own medical file; their parents do. Children aged 12 to 15 are entitled to inspect their medical records; their parents must authorize them to do so. Adolescents 16 and older may inspect their medical records without parental consent.

Scientific Research

Diabeter also conducts scientific research into the cause of diabetes and new treatments or cures. Such research is reviewed in advance by a medical-ethical review board. If we ask you to participate in a scientific study, your written consent is always required.


For a good treatment it is necessary that we, as your practitioner, create a file. Also, from the law WGBO (medical treatment agreement law) this is mandatory. We would like to explain more about data security and the privacy of you as a patient and your contacts. We also explain what we have registered about you, what we do with it and what rights you have in that respect. You can read it all here: 

How can you contact Diabeter?

If you have any questions or comments about our data protection and privacy of your medical data, you can contact Diabeter's Data Protection Officer (FG) at:  088-2807277 | email address: